TREPPIEDI, DONATELLA
 Distribuzione geografica
Continente #
NA - Nord America 3.200
EU - Europa 2.747
AS - Asia 2.378
Continente sconosciuto - Info sul continente non disponibili 221
SA - Sud America 206
AF - Africa 75
OC - Oceania 9
Totale 8.836
Nazione #
US - Stati Uniti d'America 3.073
DE - Germania 917
CN - Cina 789
SG - Singapore 642
IT - Italia 608
GB - Regno Unito 428
BD - Bangladesh 295
SE - Svezia 205
HK - Hong Kong 181
VN - Vietnam 175
BR - Brasile 153
FR - Francia 114
RU - Federazione Russa 108
CA - Canada 96
NL - Olanda 81
IN - India 77
DK - Danimarca 56
ID - Indonesia 44
FI - Finlandia 43
JP - Giappone 42
CI - Costa d'Avorio 41
IE - Irlanda 39
ES - Italia 33
TR - Turchia 28
KR - Corea 25
AR - Argentina 23
UA - Ucraina 22
MX - Messico 20
BE - Belgio 13
CH - Svizzera 13
PL - Polonia 12
ZA - Sudafrica 12
AT - Austria 11
IQ - Iraq 10
SK - Slovacchia (Repubblica Slovacca) 10
PK - Pakistan 9
AU - Australia 7
RO - Romania 7
CO - Colombia 6
EC - Ecuador 6
TW - Taiwan 6
VE - Venezuela 6
EG - Egitto 5
MY - Malesia 5
NE - Niger 5
PH - Filippine 5
TH - Thailandia 5
BY - Bielorussia 4
IL - Israele 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
SA - Arabia Saudita 4
SC - Seychelles 4
CL - Cile 3
CZ - Repubblica Ceca 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
JO - Giordania 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
NO - Norvegia 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
DZ - Algeria 2
GT - Guatemala 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
DO - Repubblica Dominicana 1
HT - Haiti 1
JM - Giamaica 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MQ - Martinica 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
YE - Yemen 1
Totale 8.615
Città #
Dallas 808
Hanover 659
Southend 373
Singapore 366
Ashburn 344
Chandler 217
Milan 196
San Jose 171
Hong Kong 154
Santa Clara 123
Beijing 115
Frankfurt am Main 97
New York 90
Ann Arbor 83
Los Angeles 74
Council Bluffs 71
Wilmington 63
Fairfield 60
Dearborn 58
Houston 58
Hefei 54
Seattle 50
Ho Chi Minh City 48
Munich 47
Princeton 46
Abidjan 41
Buffalo 41
Dublin 39
Hanoi 39
Lauterbourg 39
Toronto 36
Rome 33
Bengaluru 28
Redwood City 28
Shanghai 28
Woodbridge 28
Hangzhou 24
Cambridge 23
Nanjing 23
Helsinki 22
Jinan 22
Berlin 21
Des Moines 20
São Paulo 20
Guangzhou 19
Jakarta 19
Moscow 19
Seoul 19
Tokyo 19
Istanbul 18
Padova 18
Zhengzhou 18
Columbus 17
Chicago 16
Montreal 16
Naples 16
Tianjin 15
Phoenix 14
The Dalles 14
Boardman 13
Shenyang 12
Turin 12
Córdoba 11
Amsterdam 10
Cangzhou 10
Johannesburg 10
London 10
Haiphong 9
Nanchang 9
Nuremberg 9
Orem 9
Bernolákovo 8
Brooklyn 8
Brussels 8
Da Nang 8
Fremont 8
Hebei 8
Nantong 8
Sevilla 8
Shenzhen 8
Absecon 7
Cinisello Balsamo 7
Florence 7
Grafing 7
Hải Dương 7
Mexico City 7
Mumbai 7
San Diego 7
Turku 7
Baghdad 6
Changsha 6
Jiaxing 6
Ottawa 6
Pittsburgh 6
Plano 6
Washington 6
Wuhan 6
Bari 5
Bologna 5
Boston 5
Totale 5.559
Nome #
AZD1775: effect of monotherapy or EDP-M combination in the treatment of ACC preclinical models 460
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells 455
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant 447
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors 438
Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors 424
A novel mechanism regulating dopamine receptor type 2 (DRD2) signal transduction in pituitary tumoral cells: the role of cAMP/PKA-induced filamin A (FLNA) phosphorylation 388
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells 387
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion 386
HIGH-RESOLUTION SPATIOTEMPORAL ANALYSIS OF SOMATOSTATIN RECEPTOR TYPE 2 (SSTR2) - FILAMIN A (FLNA) INTERACTION BY SINGLE-MOLECULE IMAGING 345
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth 333
Dopamine and somatostatin analogues resistance of pituitary tumors : focus on cytoskeleton involvement 283
Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity. 274
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells 257
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 255
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation 252
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 249
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. 229
Cytoskeleton protein Filamin A is required for efficient Somatostatin receptor type 2 internalization and recycling through Rab5 and Rab4 sorting endosomes in tumor somatotroph cells 213
Filamin A (FLNA) Plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells 209
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors 204
Single-Molecule Microscopy Reveals Dynamic FLNA Interactions Governing SSTR2 Clustering and Internalization 203
Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior 191
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling 190
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells 189
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs 185
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 176
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 171
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 169
Somatostatin Receptor Type 2 (SSTR2) Internalization and Intracellular Trafficking in Pituitary GH-Secreting Adenomas: Role of Scaffold Proteins and Implications for Pharmacological Resistance 161
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells 148
Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior 120
The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells 110
Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer 106
Potential antitumoral effects through modulation of VEGF-A splicing in rat somatotroph and lactotroph pituitary tumoral cells 98
Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells 90
miR-375 Regulation of SSTR2 Expression in Corticotroph Pituitary Cells: Somatostatin Receptor Ligands Effects 41
Totale 8.836
Categoria #
all - tutte 21.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.152 0 43 57 131 156 143 138 108 149 73 27 127
2022/2023612 78 69 52 75 45 113 13 41 56 10 35 25
2023/2024502 25 24 17 36 154 11 52 46 15 40 38 44
2024/20251.144 39 66 21 121 113 65 32 99 68 152 130 238
2025/20263.718 299 886 338 261 226 139 300 101 307 219 377 265
2026/2027208 205 3 0 0 0 0 0 0 0 0 0 0
Totale 8.836